Delivery Order SPE2DB20D1100-SPE2DB25FC2J8
- Not listed
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,289.80 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml pen injectors on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors valued at $2,410.63. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors valued at $2,443.61. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for ultimate completion on April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $13,635.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The contract, which carries an ultimate completion date of July 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,995.78 on May 20, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of May 21, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA, one of the Department of...
- The Department of Defense awarded a delivery order valued at $2,278.68 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL formulations. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is funded through the Defense Logistics...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,595.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Imitrex 4 mg/0.5 mL pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This firm fixed-price delivery order, valued at $1,071.96, is scheduled for completion by September 9, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC2J8Delivery Order
The Defense Logistics Agency has awarded a $2,288.07 delivery order to AmerisourceBergen Drug Corp for IMITREX 4 mg/0.5 mL pen injectors, with an ultimate completion date of May 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and the company's corporate office is designated as both the awardee and place of performance for this order. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen Drug Corp provides essential pharmaceutical products to the Defense Health Agency and other federal healthcare systems, demonstrating the company's significant role in supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/9/25 |